Abstract
To observe the effect of Pentoxifylline for 1 year on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis (NASH). A single center, open label Randomized Control Trial. Patients were included if they had ultrasonographic evidence of fatty liver and nonalcoholic fatty liver disease activity score (NAS) ≥ 5 on liver histology. A total of 35 patients were selected; 25 of PL (Experimental) group and 10 of L (Control) group. PL group received 400 mg pentoxifylline thrice daily along with lifestyle modification and there was only lifestyle modification for the L group. After one year, NAS and fibrosis was compared in both groups. In PL group, NAS improved 2.10 ± 1.07; whereas in L group, NAS was 0.90 ± 0.99 (P = 0.006). As per the protocol analysis, NAS ≥ 2 improved in 15/20 (75%) in PL group and in 3/10 (30%) in L group (P = 0.018). In PL group, the individual component of NAS, steatosis improved from 2.30 ± 0.66 to 0.95 ± 0.76 (P = 0.000), lobular inflammation from 1.65 ± 0.59 to 1.05 ± 0.51 (P = 0.002) and hepatocyte ballooning from 1.50 ± 0.51 to 1.30 ± 0.57 (P = 0.258). In L group, steatosis improved from 2.30 ± 0.68 to 1.40 ± 1.08 (P = 0.01), lobular inflammation and hepatocyte ballooning did not improve. ...Continue Reading
References
Sep 30, 1988·Biochemical and Biophysical Research Communications·R M StrieterS L Kunkel
Jul 1, 1985·Diabetologia·D R MatthewsR C Turner
Oct 1, 1994·Gastroenterology·B R BaconB A Neuschwander-Tetri
Jun 16, 1999·Gut·I M Frayling
Sep 15, 1999·Gut·A Grant, J Neuberger
Nov 9, 2001·Biochemical and Biophysical Research Communications·V B Bhat, K M Madyastha
Oct 7, 2004·Journal of Hepatology·Sean W P KoppeRichard M Green
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David E KleinerUNKNOWN Nonalcoholic Steatohepatitis Clinical Research Network
Jun 4, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M RadfarM Abdollahi
Jul 14, 2005·Gastroenterology·Leon A AdamsPaul Angulo
Apr 4, 2007·Alimentary Pharmacology & Therapeutics·P Angulo
Feb 28, 2009·World Journal of Gastroenterology : WJG·Eugen Florin GeorgescuLiliana Vancica
Jun 1, 2008·Hepatology International·Yin-Mei LeeSeng-Gee Lim
Oct 15, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kittichai PromratRena R Wing
Apr 30, 2010·The New England Journal of Medicine·Arun J SanyalUNKNOWN NASH CRN
Jun 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giovanni MussoGianfranco Pagano
Mar 19, 2011·Journal of Clinical Gastroenterology·Alain Braillon
Jul 13, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Claudia O ZeinArthur J McCullough
May 30, 2013·World Journal of Hepatology·Shahinul AlamJahangir Kabir
Feb 28, 2014·World Journal of Gastroenterology : WJG·Juan DuYou-Ming Li
Oct 29, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·William AlazawiGraham R Foster
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Feb 3, 2016·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Shahinul AlamA K M Khorshed Alam
Apr 3, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A LonardoG Targher
Citations
Mar 7, 2019·The American Journal of Gastroenterology·Amanda CheungMary E Rinella
Oct 23, 2019·Journal of Translational Internal Medicine·Shahinul AlamNazmul Hasan
Jun 17, 2020·Expert Opinion on Pharmacotherapy·Joeri LambrechtFrank Tacke
Jul 2, 2020·Cancers·Benoit SmeuninxMark A Febbraio
Jun 1, 2019·Pharmacology Research & Perspectives·Manca PovsicJuliana Bottomley
Dec 8, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Anna RoskillyIan A Rowe
Dec 29, 2020·Diabetes, Obesity & Metabolism·Simona PanunziGeltrude Mingrone
Apr 22, 2021·PloS One·Dimitrios A KoutoukidisPaul Aveyard
Oct 15, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·David S H Bell